Pathfinder Cell Therapy Inc (PFND)
0.00
USD |
OTCM |
Sep 26, 16:00
Pathfinder Cell Therapy Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2013 | -0.4607 |
| June 30, 2013 | -0.4905 |
| March 31, 2013 | -0.4528 |
| December 31, 2012 | -0.7906 |
| September 30, 2012 | -0.7209 |
| June 30, 2012 | -0.7795 |
| March 31, 2012 | -0.8747 |
| December 31, 2011 | -0.4498 |
| September 30, 2011 | -0.5962 |
| June 30, 2011 | -0.6744 |
| March 31, 2011 | -0.561 |
| December 31, 2010 | -0.8729 |
| September 30, 2010 | -0.2079 |
| June 30, 2010 | 0.9759 |
| March 31, 2010 | 0.1876 |
| December 31, 2009 | 0.0083 |
| September 30, 2009 | 0.048 |
| June 30, 2009 | 0.0818 |
| March 31, 2009 | 0.0621 |
| December 31, 2008 | 0.0028 |
| September 30, 2008 | 0.016 |
| June 30, 2008 | 0.1356 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.021 |
| September 30, 2006 | 0.0188 |
| June 30, 2006 | 0.0249 |
| March 31, 2006 | -0.2709 |
| December 31, 2005 | 0.2985 |
| September 30, 2005 | 0.2407 |
| June 30, 2005 | 0.0969 |
| March 31, 2005 | 0.0626 |
| December 31, 2004 | 0.0745 |
| September 30, 2004 | 0.0679 |
| June 30, 2004 | 0.0574 |
| March 31, 2004 | 0.0438 |
| December 31, 2003 | 6.111 |
| September 30, 2003 | -4.074 |
| June 30, 2003 | 0.4741 |
| March 31, 2003 | -1.964 |
| December 31, 2002 | -0.1746 |
| September 30, 2002 | -0.214 |
| June 30, 2002 | -0.3235 |
| March 31, 2002 | -0.3901 |
| December 31, 2001 | -0.2893 |
| September 30, 2001 | -0.1027 |
| June 30, 2001 | -0.0028 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.039M |
| Total Liabilities (Quarterly) | 6.769M |
| Shareholders Equity (Quarterly) | -6.73M |